Sanofi
SNY
713 hedge funds and large institutions have $12.6B invested in Sanofi in 2024 Q1 according to their latest regulatory filings, with 84 funds opening new positions, 299 increasing their positions, 202 reducing their positions, and 71 closing their positions.
48% more repeat investments, than reductions
Existing positions increased: 299 | Existing positions reduced: 202
23% more call options, than puts
Call options by funds: $76.8M | Put options by funds: $62.4M
18% more first-time investments, than exits
New positions opened: 84 | Existing positions closed: 71
2% more capital invested
Capital invested by funds: $12.3B → $12.6B (+$258M)
0.81% more ownership
Funds ownership: 19.55% → 20.36% (+0.81%)
1% more funds holding
Funds holding: 709 → 713 (+4)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
+$136M |
| 2 |
Millennium Management
New York
|
+$87.3M |
| 3 |
Morgan Stanley
New York
|
+$72.6M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$68.8M |
| 5 |
MIP
Mondrian Investment Partners
London,
United Kingdom
|
+$58.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$162M |
| 2 |
Nuveen
Charlotte,
North Carolina
|
-$94.2M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$38.1M |
| 4 |
MIS
Morningstar Investment Services
Chicago,
Illinois
|
-$36.4M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$29.8M |
SNY Hedge Fund Activity: Q1 2024 in Review
713 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q1 2024, worth a combined $12.6B — up 2.1% from $12.3B a quarter earlier.
Buyers outnumbered sellers: 84 funds opened new SNY positions and 71 closed out — a net gain of 13 holders — while 299 added to existing stakes and 202 trimmed.
The largest buyer was Barrow, Hanley, Mewhinney & Strauss, opening a new position worth an estimated $136M. The largest seller was Fidelity Investments, cutting an estimated $162M.
- 713 institutional investors held Sanofi (SNY) as of Q1 2024, up from 709 in Q4 2023.
- Funds reported $12.6B of Sanofi stock for Q1 2024, up 2.1% quarter-over-quarter.
- 84 funds opened new Sanofi positions in Q1 2024 and 71 closed out, a net change of +13 holders.
- The largest Sanofi buyer in Q1 2024 was Barrow, Hanley, Mewhinney & Strauss, an estimated $136M added.
- The largest Sanofi seller in Q1 2024 was Fidelity Investments, an estimated $162M sold.
Based on aggregated 13F filings for Q1 2024.